Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today announced that the company is scheduled to present at the following March investor conferences: Cowen 41 st Annual Virtual Healthcare Conference on Monday, March 1, 2021 at 11:40 a.m. ET; and Oppenheimer 31 st Annual Virtual Healthcare Conference on Wednesday, March 17, 2021 at 9:20 a.m. ET.
February 23, 2021
· 1 min read